Literature DB >> 23612919

BRAF alterations in pediatric low grade gliomas and mixed neuronal-glial tumors.

Efthymios Dimitriadis1, George A Alexiou, Panagiota Tsotsou, Efthymia Simeonidi, Kalliopi Stefanaki, Amalia Patereli, Neofytos Prodromou, Nikolaos Pandis.   

Abstract

Low grade astrocytomas are the most common brain tumor in children. Recent studies have identified alterations in the BRAF serine/threonine kinase gene that result in mitogen activated protein kinase pathway activation. Herewith, we investigated the genetic changes of BRAF in pediatric low grade gliomas and their relation to pathological findings and Ki-67 proliferation index. The results showed gene fusions between KIAA1549 and BRAF in 66.7 % of tumors. The majority involved the KIAA1549-BRAF exon 16-exon 9 variant. Fusion junction between KIAA1549 exon 15 and BRAF exon 9 was found in five tumors, in which the myxoid component was the predominant. This has not been previously reported. No significant correlation was found between specific KIAA1549 and BRAF fusion junctions and Ki-67 index. All of the samples included in this study were tested for the presence of the BRAF(V600E) mutation, and no positive sample was found.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23612919     DOI: 10.1007/s11060-013-1131-5

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  25 in total

1.  Association of molecular alterations, including BRAF, with biology and outcome in pilocytic astrocytomas.

Authors:  Craig Horbinski; Ronald L Hamilton; Yuri Nikiforov; Ian F Pollack
Journal:  Acta Neuropathol       Date:  2010-01-01       Impact factor: 17.088

2.  Pathologic characteristics of pediatric intracranial pilocytic astrocytomas and their impact on outcome in 3 countries: a multi-institutional study.

Authors:  Tarik Tihan; Ayca Ersen; Ibrahim Qaddoumi; Maher A Sughayer; Sahsine Tolunay; Maysa Al-Hussaini; Joanna Phillips; Nalin Gupta; Patricia Goldhoff; Anu Baneerjee
Journal:  Am J Surg Pathol       Date:  2012-01       Impact factor: 6.394

3.  BRAF alterations in primary glial and glioneuronal neoplasms of the central nervous system with identification of 2 novel KIAA1549:BRAF fusion variants.

Authors:  Alex Lin; Fausto J Rodriguez; Matthias A Karajannis; Susan C Williams; Genevieve Legault; David Zagzag; Peter C Burger; Jeffrey C Allen; Charles G Eberhart; Eli E Bar
Journal:  J Neuropathol Exp Neurol       Date:  2012-01       Impact factor: 3.685

4.  Outcome analysis of childhood low-grade astrocytomas.

Authors:  Paul G Fisher; Tarik Tihan; Patricia T Goldthwaite; Moody D Wharam; Benjamin S Carson; Jon D Weingart; Michael X Repka; Kenneth J Cohen; Peter C Burger
Journal:  Pediatr Blood Cancer       Date:  2008-08       Impact factor: 3.167

5.  Dysembryoplastic neuroepithelial tumors share with pleomorphic xanthoastrocytomas and gangliogliomas BRAF(V600E) mutation and expression.

Authors:  Céline Chappé; Laetitia Padovani; Didier Scavarda; Fabien Forest; Isabelle Nanni-Metellus; Anderson Loundou; Sandy Mercurio; Frédéric Fina; Gabriel Lena; Carole Colin; Dominique Figarella-Branger
Journal:  Brain Pathol       Date:  2013-03-20       Impact factor: 6.508

6.  Medical, psychological, cognitive and educational late-effects in pediatric low-grade glioma survivors treated with surgery only.

Authors:  Christopher D Turner; Christine A Chordas; Cori C Liptak; Celiane Rey-Casserly; Brian L Delaney; Nicole J Ullrich; Liliana C Goumnerova; R Michael Scott; Heather C Begley; William J Fletcher; Xiaopan Yao; Susan Chi; Mark W Kieran
Journal:  Pediatr Blood Cancer       Date:  2009-09       Impact factor: 3.167

7.  Oncogenic RAF1 rearrangement and a novel BRAF mutation as alternatives to KIAA1549:BRAF fusion in activating the MAPK pathway in pilocytic astrocytoma.

Authors:  D T W Jones; S Kocialkowski; L Liu; D M Pearson; K Ichimura; V P Collins
Journal:  Oncogene       Date:  2009-04-13       Impact factor: 9.867

8.  Alterations of BRAF and HIPK2 loci predominate in sporadic pilocytic astrocytoma.

Authors:  J Yu; H Deshmukh; R J Gutmann; R J Emnett; F J Rodriguez; M A Watson; R Nagarajan; D H Gutmann
Journal:  Neurology       Date:  2009-09-30       Impact factor: 9.910

9.  BRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomas.

Authors:  Stefan Pfister; Wibke G Janzarik; Marc Remke; Aurélie Ernst; Wiebke Werft; Natalia Becker; Grischa Toedt; Andrea Wittmann; Christian Kratz; Heike Olbrich; Rezvan Ahmadi; Barbara Thieme; Stefan Joos; Bernhard Radlwimmer; Andreas Kulozik; Torsten Pietsch; Christel Herold-Mende; Astrid Gnekow; Guido Reifenberger; Andrey Korshunov; Wolfram Scheurlen; Heymut Omran; Peter Lichter
Journal:  J Clin Invest       Date:  2008-05       Impact factor: 14.808

Review 10.  MAPK pathway activation in pilocytic astrocytoma.

Authors:  David T W Jones; Jan Gronych; Peter Lichter; Olaf Witt; Stefan M Pfister
Journal:  Cell Mol Life Sci       Date:  2011-12-13       Impact factor: 9.261

View more
  9 in total

1.  Chromosome band 7q34 deletions resulting in KIAA1549-BRAF and FAM131B-BRAF fusions in pediatric low-grade Gliomas.

Authors:  Jacquelyn J Roth; Mariarita Santi; Avrum N Pollock; Brian N Harding; Lucy B Rorke-Adams; Laura S Tooke; Jaclyn A Biegel
Journal:  Brain Pathol       Date:  2014-09-12       Impact factor: 6.508

2.  Analysis of IDH1-R132 mutation, BRAF V600 mutation and KIAA1549-BRAF fusion transcript status in central nervous system tumors supports pediatric tumor classification.

Authors:  Midea Gierke; Jan Sperveslage; David Schwab; Rudi Beschorner; Martin Ebinger; Martin U Schuhmann; Jens Schittenhelm
Journal:  J Cancer Res Clin Oncol       Date:  2015-06-27       Impact factor: 4.553

3.  Therapeutic and Prognostic Implications of BRAF V600E in Pediatric Low-Grade Gliomas.

Authors:  Alvaro Lassaletta; Michal Zapotocky; Matthew Mistry; Vijay Ramaswamy; Marion Honnorat; Rahul Krishnatry; Ana Guerreiro Stucklin; Nataliya Zhukova; Anthony Arnoldo; Scott Ryall; Catriona Ling; Tara McKeown; Jim Loukides; Ofelia Cruz; Carmen de Torres; Cheng-Ying Ho; Roger J Packer; Ruth Tatevossian; Ibrahim Qaddoumi; Julie H Harreld; James D Dalton; Jean Mulcahy-Levy; Nicholas Foreman; Matthias A Karajannis; Shiyang Wang; Matija Snuderl; Amulya Nageswara Rao; Caterina Giannini; Mark Kieran; Keith L Ligon; Maria Luisa Garre; Paolo Nozza; Samantha Mascelli; Alessandro Raso; Sabine Mueller; Theodore Nicolaides; Karen Silva; Romain Perbet; Alexandre Vasiljevic; Cécile Faure Conter; Didier Frappaz; Sarah Leary; Courtney Crane; Aden Chan; Ho-Keung Ng; Zhi-Feng Shi; Ying Mao; Elizabeth Finch; David Eisenstat; Bev Wilson; Anne Sophie Carret; Peter Hauser; David Sumerauer; Lenka Krskova; Valerie Larouche; Adam Fleming; Shayna Zelcer; Nada Jabado; James T Rutka; Peter Dirks; Michael D Taylor; Shiyi Chen; Ute Bartels; Annie Huang; David W Ellison; Eric Bouffet; Cynthia Hawkins; Uri Tabori
Journal:  J Clin Oncol       Date:  2017-07-20       Impact factor: 44.544

Review 4.  An integrative molecular and genomic analysis of pediatric hemispheric low-grade gliomas: an update.

Authors:  Alvaro Lassaletta; Michal Zapotocky; Eric Bouffet; Cynthia Hawkins; Uri Tabori
Journal:  Childs Nerv Syst       Date:  2016-09-20       Impact factor: 1.475

Review 5.  Current Understanding of BRAF Alterations in Diagnosis, Prognosis, and Therapeutic Targeting in Pediatric Low-Grade Gliomas.

Authors:  Catherine Louise Penman; Claire Faulkner; Stephen P Lowis; Kathreena M Kurian
Journal:  Front Oncol       Date:  2015-03-03       Impact factor: 6.244

6.  Genome sequencing identifies somatic BRAF duplication c.1794_1796dupTAC;p.Thr599dup in pediatric patient with low-grade ganglioglioma.

Authors:  Katherine E Miller; Benjamin Kelly; James Fitch; Nicole Ross; Matthew R Avenarius; Elizabeth Varga; Daniel C Koboldt; Daniel R Boué; Vincent Magrini; Scott L Coven; Jonathan L Finlay; Catherine E Cottrell; Peter White; Julie M Gastier-Foster; Richard K Wilson; Jeffrey Leonard; Elaine R Mardis
Journal:  Cold Spring Harb Mol Case Stud       Date:  2018-04-02

Review 7.  Pediatric low-grade glioma in the era of molecular diagnostics.

Authors:  Scott Ryall; Uri Tabori; Cynthia Hawkins
Journal:  Acta Neuropathol Commun       Date:  2020-03-12       Impact factor: 7.801

8.  BRAF Fusion Analysis in Pilocytic Astrocytomas: KIAA1549-BRAF 15-9 Fusions Are More Frequent in the Midline Than Within the Cerebellum.

Authors:  Claire Faulkner; Hayley Patricia Ellis; Abigail Shaw; Catherine Penman; Abigail Palmer; Christopher Wragg; Mark Greenslade; Harry Russell Haynes; Hannah Williams; Stephen Lowis; Paul White; Maggie Williams; David Capper; Kathreena Mary Kurian
Journal:  J Neuropathol Exp Neurol       Date:  2015-09       Impact factor: 3.685

9.  Targeted therapy by combined inhibition of the RAF and mTOR kinases in malignant spindle cell neoplasm harboring the KIAA1549-BRAF fusion protein.

Authors:  Vivek Subbiah; Shannon N Westin; Kai Wang; Dejka Araujo; Wei-Lien Wang; Vincent A Miller; Jeffrey S Ross; Phillip J Stephens; Gary A Palmer; Siraj M Ali
Journal:  J Hematol Oncol       Date:  2014-01-14       Impact factor: 17.388

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.